Rocket Pharmaceuticals Stock Probability of Future Stock Price Finishing Under 11.56
| RCKT Stock | USD 11.56 0.21 1.85% |
Rocket |
Rocket Pharmaceuticals Target Price Odds to finish below 11.56
The tendency of Rocket Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 11.56 | 90 days | 11.56 | under 4 |
Based on a normal probability distribution, the odds of Rocket Pharmaceuticals to move below current price in 90 days from now is under 4 (This Rocket Pharmaceuticals probability density function shows the probability of Rocket Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.59 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Rocket Pharmaceuticals will likely underperform. Additionally Rocket Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Rocket Pharmaceuticals Price Density |
| Price |
Predictive Modules for Rocket Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Rocket Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Rocket Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Rocket Pharmaceuticals is not an exception. The market had few large corrections towards the Rocket Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Rocket Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Rocket Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.91 | |
β | Beta against Dow Jones | 1.59 | |
σ | Overall volatility | 2.34 | |
Ir | Information ratio | -0.26 |
Rocket Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Rocket Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Rocket Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Rocket Pharmaceuticals generated a negative expected return over the last 90 days | |
| Rocket Pharmaceuticals has high historical volatility and very poor performance | |
| Net Loss for the year was (245.59 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Rocket Pharmaceuticals currently holds about 321.37 M in cash with (194.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.87. | |
| Rocket Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Over 92.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Disposition of 57273 shares by Jonathan Schwartz of Rocket Pharmaceuticals at 30.01 subject to Rule 16b-3 |
Rocket Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Rocket Stock often depends not only on the future outlook of the current and potential Rocket Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Rocket Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 84 M | |
| Cash And Short Term Investments | 373.2 M |
Rocket Pharmaceuticals Technical Analysis
Rocket Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Rocket Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Rocket Pharmaceuticals. In general, you should focus on analyzing Rocket Stock price patterns and their correlations with different microeconomic environments and drivers.
Rocket Pharmaceuticals Predictive Forecast Models
Rocket Pharmaceuticals' time-series forecasting models is one of many Rocket Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Rocket Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Rocket Pharmaceuticals
Checking the ongoing alerts about Rocket Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Rocket Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Rocket Pharmaceuticals generated a negative expected return over the last 90 days | |
| Rocket Pharmaceuticals has high historical volatility and very poor performance | |
| Net Loss for the year was (245.59 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Rocket Pharmaceuticals currently holds about 321.37 M in cash with (194.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.87. | |
| Rocket Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Over 92.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Disposition of 57273 shares by Jonathan Schwartz of Rocket Pharmaceuticals at 30.01 subject to Rule 16b-3 |
Additional Tools for Rocket Stock Analysis
When running Rocket Pharmaceuticals' price analysis, check to measure Rocket Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rocket Pharmaceuticals is operating at the current time. Most of Rocket Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rocket Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rocket Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rocket Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.